Provider Shortage Could Curtail Health Reform Gains For Diabetics
This article was originally published in The Gray Sheet
Executive SummaryThe U.S. health care reform law and its insurance coverage expansion will help improve the lives of patients with diabetes, but an ongoing provider shortage threatens to counter any positive effect, analysts warn.
You may also be interested in...
Bio-Thera, which has just started selling China’s first adalimumab biosimilar rival to AbbVie’s top-selling arthritis treatment Humira, has raised $241m in an IPO on the Shanghai Stock Exchange.
In a shocking and revealing account, a primary investigator of the front-runner antiviral drug for the coronavirus in China expresses concerns over finding enough patients for the study Wuhan, the outbreak's epicenter.